Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]        
Revenue $ 513
Operating costs and expenses:        
Inventor royalties, contingent legal fees, litigation and licensing expenses 385
Research and development expenses (including non-cash share-based compensation expenses of $966, $447, $2,243 and $737, respectively) 1,735 1,022 3,573 1,850
General and administrative expenses (including non-cash share-based compensation expenses of $715, $604, $1,793 and $1,300, respectively) 1,854 1,415 3,896 2,948
Total operating costs and expenses 3,589 2,437 7,469 5,183
Loss from operations (3,589) (2,437) (7,469) (4,670)
Interest income 1 2 1
Net loss (3,588) (2,437) (7,467) (4,669)
Less: Net loss attributable to noncontrolling interest (44) (38) (94) (62)
Net loss attributable to common shareholders $ (3,544) $ (2,399) $ (7,373) $ (4,607)
Net loss per common share attributable to common shareholders:        
Basic and diluted $ (0.12) $ (0.08) $ (0.24) $ (0.17)
Weighted average common shares outstanding:        
Basic and diluted 30,152 28,669 30,138 26,888